FALLOPIAN TUBE TRANSITIONAL CELL CARCINOMA
Clinical trials for FALLOPIAN TUBE TRANSITIONAL CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new FALLOPIAN TUBE TRANSITIONAL CELL CARCINOMA trials appear
Sign up with your email to follow new studies for FALLOPIAN TUBE TRANSITIONAL CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Major trial tests if abdominal chemo beats IV for tough cancers
Disease control CompletedThis large Phase III trial tested whether adding the drug bevacizumab to chemotherapy works better when the chemo is given into a vein (IV) or directly into the belly (IP). It involved 1560 people with advanced ovarian, fallopian tube, or peritoneal cancers. The goal was to see w…
Matched conditions: FALLOPIAN TUBE TRANSITIONAL CELL CARCINOMA
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Could a custom vaccine help fight ovarian cancer?
Disease control CompletedThis early-phase trial tested a personalized vaccine made from a patient's own immune cells to see if it is safe for people with advanced ovarian, fallopian tube, or peritoneal cancer. Nineteen participants who had already undergone surgery and chemotherapy received the vaccine. …
Matched conditions: FALLOPIAN TUBE TRANSITIONAL CELL CARCINOMA
Phase: EARLY_PHASE1 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC